|Immunogen||VZV Ellen Strain from VZV-infected monkey kidney cells (BSC-1).|
|Purification||Protein G Chromatography|
|Target/Specificity||Reacts only with fully glycosylated VZV glycoprotein I (VZVgE) as well as glycoprotein IV (VZVgI) by immunoprecipitation.|
|Storage||Short term (up to 7 days) store at 2-8°C. Long term, aliquot and store at -20°C. Avoid multiple freeze/thaw cycles.|
|Precautions||Monoclonal Antibody to Varicella-Zoster Virus (VZV), gpI and IV [SG1-1] is for research use only and not for use in diagnostic or therapeutic procedures.|
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
The references listed below are for research purposes only:1. Rahaus, M., et al., (2003), “Transcription factor USF, expressed during the entire phase of varicella-zoster virus infection, interacts physically with the major viral transactivator IE62 and plays a significant role in virus replication”, Journal of General Virology, 84: 2957-2967.2. Rahaus, M., et al., (2004), “Replication of varicella-zoster virus is influenced by the levels of JNK/SAPK and p38/MAPK activation”, Journal of General Virology, 85: 3529-3540.3. Weller, T.H., (1979), “Varicella and Herpes Zoster. In:Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections”, (Lennette, E.H. and Schmidt, N.J., eds.) American Public Health Associations, Inc. Washington D.C., pp 375-398.4. Drew, W.L., et al., (1980), “Rapid diagnosis of varicella-zoster virus infection by direct immunofluorescence”, Am. J. Clin. Pathol., 73:699-701.5. Davison, et al., (1986), “New common nomenclature for glycoprotein gene of varicella-zoster virus and their glycosylated products”, J. Virol., 57:1195-1197.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.